These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2176090)

  • 1. 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells.
    O'Connor PM; Kerrigan D; Bertrand R; Kohn KW; Pommier Y
    Cancer Commun; 1990; 2(12):395-400. PubMed ID: 2176090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials.
    Tanizawa A; Fujimori A; Fujimori Y; Pommier Y
    J Natl Cancer Inst; 1994 Jun; 86(11):836-42. PubMed ID: 8182764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.
    Valenti M; Nieves-Neira W; Kohlhagen G; Kohn KW; Wall ME; Wani MC; Pommier Y
    Mol Pharmacol; 1997 Jul; 52(1):82-7. PubMed ID: 9224816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells.
    O'Connor PM; Nieves-Neira W; Kerrigan D; Bertrand R; Goldman J; Kohn KW; Pommier Y
    Cancer Commun; 1991 Aug; 3(8):233-40. PubMed ID: 1653585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.
    Covey JM; Jaxel C; Kohn KW; Pommier Y
    Cancer Res; 1989 Sep; 49(18):5016-22. PubMed ID: 2548707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.
    Pommier Y; Kohlhagen G; Kohn KW; Leteurtre F; Wani MC; Wall ME
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8861-5. PubMed ID: 7568032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
    Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
    Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.
    Ciesielski MJ; Fenstermaker RA
    J Neurooncol; 1999 Feb; 41(3):223-34. PubMed ID: 10359142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocamptothecin, an E-ring-modified camptothecin, exerts more potent antiproliferative activity than other topoisomerase I inhibitors in human colon cancers obtained from surgery and maintained in vitro under histotypical culture conditions.
    Philippart P; Harper L; Chaboteaux C; Decaestecker C; Bronckart Y; Gordover L; Lesueur-Ginot L; Malonne H; Lavergne O; Bigg DC; da Costa PM; Kiss R
    Clin Cancer Res; 2000 Apr; 6(4):1557-62. PubMed ID: 10778989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of hyperthermia and CPT-11 on DNA strand breaks in mouse mammary carcinoma FM3A cells.
    Kondo T; Ueda K; Kano E
    Anticancer Res; 1995; 15(1):83-6. PubMed ID: 7733646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyguanosine enhances the cytotoxicity of the topoisomerase I inhibitor camptothecin by reducing the repair of double-strand breaks induced in replicating DNA.
    Squires S; Ryan AJ; Strutt HL; Smith PJ; Johnson RT
    J Cell Sci; 1991 Dec; 100 ( Pt 4)():883-93. PubMed ID: 1726104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
    Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
    Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Kaufmann SH
    Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.
    Walsh MD; Hanna SK; Sen J; Rawal S; Cabral CB; Yurkovetskiy AV; Fram RJ; Lowinger TB; Zamboni WC
    Clin Cancer Res; 2012 May; 18(9):2591-602. PubMed ID: 22392910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells.
    Bertrand R; O'Connor PM; Kerrigan D; Pommier Y
    Eur J Cancer; 1992; 28A(4-5):743-8. PubMed ID: 1326304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
    Kim JS; Amorino GP; Pyo H; Cao Q; Choy H
    Radiother Oncol; 2002 Jan; 62(1):61-7. PubMed ID: 11830313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.